U.S.: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in the U.S.

The U.S. medicaments containing hormones market soared to $X in 2022, jumping by X% against the previous year. Over the period under review, consumption enjoyed resilient growth. As a result, consumption attained the peak level of $X. From 2021 to 2022, the growth of the market failed to regain momentum.

Medicaments Containing Hormones Production in the U.S.

In value terms, medicaments containing hormones production rose remarkably to $X in 2022. Over the period under review, the total production indicated tangible growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The pace of growth was the most pronounced in 2020 with an increase of X%. As a result, production attained the peak level of $X. From 2021 to 2022, production growth failed to regain momentum.

Medicaments Containing Hormones Exports

Exports from the U.S.

In 2022, the amount of medicaments containing hormones but not antibiotics exported from the United States declined rapidly to X tons, falling by X% on the previous year. Overall, exports recorded a abrupt decrease. The most prominent rate of growth was recorded in 2021 with an increase of X%. The exports peaked at X tons in 2013; however, from 2014 to 2022, the exports failed to regain momentum.

In value terms, medicaments containing hormones exports reduced to $X in 2022. Over the period under review, total exports indicated a mild increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2018 indices. The most prominent rate of growth was recorded in 2021 when exports increased by X%. Over the period under review, the exports reached the maximum at $X in 2013; however, from 2014 to 2022, the exports remained at a lower figure.

Exports by Country

Canada (X tons), Switzerland (X tons) and Denmark (X tons) were the main destinations of medicaments containing hormones exports from the United States, with a combined X% share of total exports.

From 2012 to 2022, the biggest increases were recorded for Denmark (with a CAGR of X%), while shipments for the other leaders experienced mixed trend patterns.

In value terms, Switzerland ($X) remains the key foreign market for medicaments containing hormones but not antibiotics exports from the United States, comprising X% of total exports. The second position in the ranking was taken by Denmark ($X), with a X% share of total exports. It was followed by Ireland, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to Switzerland stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Denmark (X% per year) and Ireland (X% per year).

Export Prices by Country

In 2022, the average medicaments containing hormones export price amounted to $X per ton, rising by X% against the previous year. Overall, the export price posted a buoyant expansion. The most prominent rate of growth was recorded in 2020 when the average export price increased by X%. Over the period under review, the average export prices reached the peak figure in 2022 and is likely to continue growth in the near future.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was Ireland ($X,999 per ton), while the average price for exports to Canada ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Ireland (X%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Hormones Imports

Imports into the U.S.

For the fourth year in a row, the United States recorded growth in supplies from abroad of medicaments containing hormones but not antibiotics, which increased by X% to X tons in 2022. Overall, imports continue to indicate a significant increase. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. Over the period under review, imports attained the peak figure in 2022 and are expected to retain growth in the immediate term.

In value terms, medicaments containing hormones imports surged to $X in 2022. Over the period under review, imports recorded prominent growth. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. Imports peaked in 2022 and are likely to see steady growth in the immediate term.

Imports by Country

In 2022, Denmark (X tons) was the main supplier of medicaments containing hormones to the United States, with a X% share of total imports. Moreover, medicaments containing hormones imports from Denmark exceeded the figures recorded by the second-largest supplier, India (X tons), more than tenfold. The third position in this ranking was held by Belgium (X tons), with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Denmark amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: India (X% per year) and Belgium (X% per year).

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to the United States, comprising X% of total imports. The second position in the ranking was held by India ($X), with an X% share of total imports. It was followed by Belgium, with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from Denmark stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: India (X% per year) and Belgium (X% per year).

Import Prices by Country

The average medicaments containing hormones import price stood at $X per ton in 2022, waning by X% against the previous year. Overall, the import price saw a abrupt decline. The growth pace was the most rapid in 2018 an increase of X% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2013; however, from 2014 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Belgium ($X per ton), while the price for Denmark ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Portugal (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :